文献速递神经外科与老年麻醉术前评估与围术期医学

老年患者七氟烷联合瑞芬太尼麻醉下瑞马唑仑与丙泊酚诱导后低血压比较

Hypotension after general anaesthesia induction using remimazolam or propofol in geriatric patients undergoing sevoflurane anaesthesia with remifentanil: a single-centre, double-blind, randomised controlled trial.
PubMed 文献 · Br J Anaesth · 2024-05-22

这项单中心双盲随机对照试验纳入90例≥80岁择期手术老年患者,比较瑞马唑仑与丙泊酚诱导后低血压发生率。结果显示两组低血压发生率分别为72.1%和72.7%,无统计学差异(校正OR 0.96,95%CI 0.37-2.46,P=0.93),亚组分析亦无显著差异。

要点

  • 瑞马唑仑未降低≥80岁患者全麻诱导后低血压发生率
  • 两组低血压发生率均约72%,无统计学差异
  • 亚组分析(术前病房高血压、临床衰弱量表、Charlson合并症指数、年龄)未见组间差异

核心结论

  • 与丙泊酚相比,瑞马唑仑未降低≥80岁患者全麻诱导后低血压发生率。

研究设计与样本

  • 单中心、双盲、随机对照试验,纳入90例≥80岁择期手术全麻患者,随机接受瑞马唑仑(12 mg kg-1 h-1)或丙泊酚(0.025 mg kg-1 s-1)诱导,联合瑞芬太尼和七氟烷麻醉,以病房高血压与否为分层因素。

主要发现

  • 给药前排除3例,87例纳入分析。
  • 瑞马唑仑组低血压发生率为72.1%(31/43),丙泊酚组为72.7%(32/44)。
  • 两组比较无统计学显著差异(校正OR 0.96,95%CI 0.37-2.46,P=0.93)。
  • 亚组分析(术前病房高血压、临床衰弱量表、Charlson合并症指数、年龄)未见组间显著差异。

关键数值与推荐

  • 低血压定义为从开始给药至气管插管后3分钟内每分钟测量的无创平均动脉压<65 mm Hg。

临床怎么用

  • 对于≥80岁老年患者,选择瑞马唑仑或丙泊酚诱导时,均应预期并防范诱导后低血压的高发生率。

局限性

  • 单中心设计,样本量较小(87例纳入分析),可能限制结果外推。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The occurrence of hypotension after induction of general anaesthesia is common in geriatric patients, and should be prevented to minimise perioperative complications. Compared with propofol, remimazolam potentially has a lower incidence of hypotension. This study aimed to compare the incidence of hypotension after general anaesthesia induction with remimazolam or propofol in geriatric patients. METHODS: This single-centre, double-blind, randomised trial enrolled 90 patients aged ≥80 yr who received general anaesthesia for scheduled surgery. Patients were randomised to receive remimazolam (12 mg kg-1 h-1) or propofol (0.025 mg kg-1 s-1) for anaesthesia induction, with remifentanil and sevoflurane. The presence or absence of hypertension on the ward served as the stratification factor. The incidence of hypotension after the induction of general anaesthesia, defined as a noninvasive mean arterial pressure of <65 mm Hg measured every minute from initiation of drug administration to 3 min after tracheal intubation, was the primary outcome. Subgroup analysis was performed for the primary outcome using preoperative ward hypertension, clinical frailty scale, Charlson Comorbidity Index, and age. RESULTS: Three subjects were excluded before drug administration, and 87 subjects were included in the analysis. The incidence of hypotension was 72.1% (31/43) and 72.7% (32/44) with remimazolam or propofol, respectively. No statistically significant differences (adjusted odds ratio, 0.96; 95% confidence interval, 0.37-2.46; P=0.93) were observed between groups. Subgroup analysis revealed no significant differences between groups. CONCLUSIONS: Compared with propofol, remimazolam did not reduce the incidence of hypotension after general anaesthesia induction in patients aged ≥80 yr. CLINICAL TRIAL REGISTRATION: UMIN000042587.

来源:Br J Anaesth,查看原文。版权归原作者所有。

引用

  1. Takaki R, Yokose M, Mihara T, et al. Hypotension after general anaesthesia induction using remimazolam or propofol in geriatric patients undergoing sevoflurane anaesthesia with remifentanil: a single-centre, double-blind, randomised controlled trial. Br J Anaesth. 2024. PMID: 38777646. doi:10.1016/j.bja.2024.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。